Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final...

13
Session No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30 Main Live Demonstration SFA intervention (DES or DCB) Language English MODERATOR Yoshiaki Yokoi MODERATOR Kazushi Urasawa FACILITATOR Masahiko Fujihara PANEL Michael Dake PANEL Steven Kum PANEL Chun-Chi Chen PANEL Kentaro Jujo PANEL Amane Kozuki (Kansai Rosai) Operator Osamu Iida Theme SFA-DES(TASC-C/D) non-calc (Morinomiya) Operator Hiroyoshi Yokoi Theme SFA-DCB(TASC-A/B) non-calc Short Lecture Speech (min) Title and Speaker 1. 7 Zilver PTX: DES is the way to go for SFA treatment with solid data Michael Dake 2. 7 Lutonix DCB: Proved DCB in many DCBs Steven Kum

Transcript of Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final...

Page 1: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A1

Drug technology is the final solution for complex SFA disease?

Session No A1

Friday, February 23rd, 2018 09:00-10:30

Main Live Demonstration

SFA intervention (DES or DCB)

Language English

MODERATOR Yoshiaki Yokoi

MODERATOR Kazushi Urasawa

FACILITATOR Masahiko Fujihara

PANEL Michael Dake

PANEL Steven Kum

PANEL Chun-Chi Chen

PANEL Kentaro Jujo

PANEL Amane Kozuki

(Kansai Rosai) Operator Osamu Iida

Theme SFA-DES(TASC-C/D) non-calc

(Morinomiya) Operator Hiroyoshi Yokoi

Theme SFA-DCB(TASC-A/B) non-calc

Short

Lecture

Speech

(min) Title and Speaker

1. 7 Zilver PTX: DES is the way to go for SFA treatment with solid data

Michael Dake

2. 7 Lutonix DCB: Proved DCB in many DCBs

Steven Kum

Page 2: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A2

Viabahn is the choice for complex femoropopliteal disease?

Session No A2

Friday, February 23rd, 2018 10:30-12:00

Main Live Demonstration

SFA intervention (DES or Endoluminal Bypass?)

Language English

MODERATOR Masato Nakamura

MODERATOR Kimihiko Kichikawa

FACILITATOR Masahiko Fujihara

PANEL Lawrence A. Garcia

PANEL Matthew C Becker

PANEL Wei-Kung Tseng

PANEL Michiaki Higashitani

PANEL Masanori Inoue

(Kansai Rosai) Operator Osamu Iida

Theme SFA-Viabahn(TASC-C/D) non-calc

(Morinomiya) Operator Daizo Kawasaki

Theme SFA-DES+DEB(TASC-C/D) non-calc

Short

Lecture

Speech

(min) Title and Speaker

A 7 Viabahn for long SFA disease: Only proved treatment

Matthew C Becker

B 7 How do I indicate DCB and DES for complex SFA disease?

Lawrence A. Garcia

Page 3: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. Opening ceremony

Session No. Opening ceremony

Friday, February 23rd, 2018 13:20-13:40

Opening ceremony

Language English

Attendee JET Board Members

Time Speech

(min)

Discussion

(min) Title and Speaker

13:20 2 - The History of JET (movie 2min)

13:20- 3 - Introduction

Hiroyoshi Yokoi

09:05- 10 - JET for the last 10 years and next 10 years

Yoshiaki Yokoi

09:18- 5 -

JET award 2018 ‘‘Dr. John R. Laird ‘

Presenter; Yoshiaki Yokoi

The prize winner, John R. Laird

Page 4: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A3

SFA CTO: True, false or it does matter?

Session No A3

Friday, February 23rd, 2018 13:40-15:10

Main Live Demonstration

SFA intervention (OUTBACK or TruePath)

Language English

MODERATOR Yoshiaki Yokoi

MODERATOR Hiroyoshi Yokoi

FACILITATOR Shigeo Ichihashi

PANEL Koen Deloose

PANEL Donghoon Choi

PANEL Young guk Ko

PANEL Hiroshi Ando

PANEL Kan Zen

(Kansai Rosai) Operator Osamu Iida

Theme SFA-TruePath (any TASC) with calc

(Morinomiya) Operator Daizo Kawasaki

Theme SFA-OUTBACK (TASC C/D) without calc

Short

Lecture

Speech

(min) Title and Speaker

A 7 TRUEPATH for true lumen recanalizer

Hiroshi Ando

B 7 OUTBACK: True savior for CTO

Donghoon Choi

Page 5: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A4

Next-Generation BEStent-Graft for AIOD

Session No A4

Friday, February 23rd, 2018 15:40-17:10

Main Live Demonstration

Iliac intervention (BNS or Iliac Stent Graft)

Language English

MODERATOR Hiroyoshi Yokoi

MODERATOR Shinsuke Nanto

FACILITATOR Kenji Suzuki

PANEL Michael Dake

PANEL Ralf Langhoff

PANEL Chia-Hsun Lin

PANEL Shigeru Nakamura

PANEL Norihiko Shinozaki

(Kansai Rosai) Operator Osamu Iida

Theme Aorto-Iliac lesion (Viabahn BVX)

(Morinomiya) Operator Yoshimitsu Soga

Theme Aorto-Iliac lesion(Protage/Everflex)

Short

Lecture

Speech

(min) Title and Speaker

A 7 Viabahn VBX: Don't worry iliac perforation

Michael Dake

B 7 Medtronic Iliac stent: Simple is the best

Ralf Langhoff

Page 6: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A5

Challenging for BTK complex cases

Session No A5

Friday, February 23rd, 2018 17:10-18:40

Main Live Demonstration

BTK intervention (Crosser or PTA)

Language English

MODERATOR Yoshiaki Yokoi

MODERATOR Naoto Inoue

FACILITATOR Tatsuya Nakama

PANEL Ramon Varcoe

PANEL Bryan Yan

PANEL Hsuan Li Huang

PANEL Osami Kawarada

PANEL Toshifumi Kudo

(Kansai Rosai) Operator Kazushi Urasawa

Theme BTK lesion with CLI

(Morinomiya) Operator Daizo Kawasaki

Theme BTK lesion with CLI

Short

Lecture

Speech

(min) Title and Speaker

A 7 How do I intervene complex BTK lesions?

Osami Kawarada

B 7 How to dilate diffuse tibial artery disease?

Bryan Yan

Page 7: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A6

Finally arrived DCB in Japan (How do we incorporate two DCBs in SFA disease ?)

Session No A6

Saturday, February 24th, 2018 09:00-10:30

Main Live Demonstration

SFA intervention (INPACT vs LUTONIX)

Language English

MODERATOR Osamu Iida

MODERATOR Yoshimitsu Soga

FACILITATOR Makoto Utsunomiya

PANEL John R. Laird

PANEL Fabrizio Fanelli

PANEL Jer - Shen Chen

PANEL Taketsugu Tsuchiya

PANEL Tomoaki Umemoto

(Kishiwada) Operator Yoshiaki Yokoi

Theme SFA-DCB (TASC-A/B) LUTONIX DCB

(Morinomiya) Operator Shigeru Nakamura

Theme SFA-DCB (TASC-A-C) INPACT DCB

Short

Lecture

Speech

(min) Title and Speaker

A 7 How to optimize your practice with Lutonix DCB

Seung-When Lee

B 7 Impact gives more impact in my practice

John R. Laird

Page 8: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A7

Strategy of SFA-calcified lesion

Session No A7

Saturday, February 24th, 2018 10:30-12:00

Main Live Demonstration

SFA intervention (Calcified Lesion)

Language English

MODERATOR Osamu Iida

MODERATOR Nobuyoshi Azuma

FACILITATOR Makoto Utsunomiya

PANEL Donghoon Choi

PANEL Yann Gouëffic

PANEL Sung - Yu Chu

PANEL Yusuke Miyashita

PANEL Tomoyasu Sato

(Kishiwada) Operator Hiroyoshi Yokoi

Theme SFA-BMS (TASC C/D) calc

(Morinomiya) Operator Daizo Kawasaki

Theme SFA-BMS (TASC C/D) calc

Short

Lecture

Speech

(min) Title and Speaker

A 7 My strategy for calcified SFA lesion

Yann Gouëffic

B 7 How do I assess and intervene calcified SFA lesions?

Donghoon Choi

Page 9: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A8

Fight for calcification lesions

Session No A8

Saturday, February 24th, 2018 13:20-14:50

Main Live Demonstration

SFA intervention (VIABAHN calc or no calc)

Language English

MODERATOR Masato Nakamura

MODERATOR Kimihiko Kichikawa

FACILITATOR Terutoshi Yamaoka

PANEL Andrej Schmidt

PANEL Mehdi H. Shishehbor

PANEL Chung-Ho Hsu

PANEL Nobuhiko Ogata

PANEL Naoki Fujimura

(Kishiwada) Operator Masahiko Fujihara

Theme SFA-Viabahn (TASC C/D) non-calc

(Morinomiya) Operator Daizo Kawasaki

Theme SFA-Viabahn (TASC C/D) calc

Short

Lecture

Speech

(min) Title and Speaker

A 7 How to use VIABAHN for diffuse SFA lesion

Chung-Ho Hsu

B 7 German style for calcified SFA lesion

Andrej Schmidt

Page 10: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A9

Balloon expanding or Self expanding, which is the better?

Session No A9

Saturday, February 24th, 2018 14:50-16:20

Main Live Demonstration

Iliac intervention (BES or SES)

Language English

MODERATOR Osamu Iida

MODERATOR Hiroshi Ando

FACILITATOR Tatsuya Shiraki

PANEL Ehrin J. Armstrong

PANEL Ki Hyuck Park

PANEL Yoshiaki Shintani

PANEL Shinya Sasaki

(Kishiwada) Operator Kan Zen

Theme Aorto-Iliac lesion

(Morinomiya) Operator Shigeru Nakamura

Theme Aorto-Iliac lesion

Short

Lecture

Speech

(min)

A 7 Title and Speaker

A

B

7

7

My favorite Iliac stent

Ki Hyuck Park

B 7 Old SMART is good enough

Page 11: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A10

Special technique from Japan in BTK field

Session No A10

Saturday, February 24th, 2018 16:50-18:20

Main Live Demonstration

Complex BTK and BTA intervention

Language English

MODERATOR Yoshimitsu Soga

MODERATOR Kazushi Urasawa

FACILITATOR Kenji Suzuki

PANEL Marco Manzi

PANEL Jackie Ho

PANEL Po-Jen Ko

PANEL Yoshito Yamamoto

PANEL Takao Okamura

(Kishiwada) Operator Tatsuya Nakama

Theme BTK lesion with CLI

(Morinomiya) Operator Hiroshi Ando

Theme BTK lesion with CLI

Short

Lecture

Speech

(min) Title and Speaker

A 7 Italian style for complex BTK disease

Marco Manzi

B 7 Singapore style for complex BTK disease

Jackie Ho

Page 12: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A11

Session No A11

Sunday, February 25th, 2018 9:00-10:30

日本下肢救済・足病学会 x JET

Yes! We will be a Podiatrists! JLSPM@JET2018 part 1

Language Japanese

MODERATOR 横井 宏佳

MODERATOR 仲間 達也

PANEL 寺師 浩人

PANEL 藤井 美樹

PANEL 寺部 雄太

Time Speech

(min)

Discussion

(min) Title and Speaker

09:00- 5 Introduction

横井 宏佳

09:05- 15 5 CLI 患者に対する血行再建後の創傷治癒の現状

仲間 達也

09:20- 7 5 僕、内科医ですがここまでやっちゃいます

伊元 裕樹

09:40- 7 5 創傷処置をせぬもの、東部の循環器内科医にあらず

小林 範弘

10:00- 7 5 私、血管外科医ですから!

久良木 亮一

10:20- 5 Conclusion and Summary

仲間 達也

Page 13: Session No. A1 - 一般社団法人 Japan Endovascular ... No. A1 Drug technology is the final solution for complex SFA disease? Session No A1 Friday, February 23rd, 2018 09:00-10:30

Session No. A12

Session No A12

Sunday, February 25th, 2018 10:30-12:00

Hall A

日本下肢救済・足病学会 xJET

Yes! We will be a Podiatrists!JLSPM@JET2018 part 2

Language Japanese

MODERATOR 横井 宏佳

MODERATOR 仲間 達也

PANEL 大浦 紀彦

PANEL 市岡 滋

PANEL 古川 雅英

Time Speech

(min)

Discussion

(min) Title and Speaker

10:30- 5 Introduction

横井 宏佳

10:35- 10 で、結局誰が傷を見た方が良いのか?

藤原 昌彦

10:45- 20 外科医としての EVT を介した CLI との付き合い方

郡谷 篤史

11:05- 20

跛行へはリハビリ。CLI へは創傷管理。

それが森之宮スタイル

福永 匡史

11:25- 20 血管外科医は、ここまでできる

東 信良

11:45 10 Discussion

11:55- 5 Conclusion and Summary

仲間 達也